General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Novartis Corporation(MODEST), Kaneka(MODEST), New Amsterdam(MODEST) RESEARCH/RESEARCH GRANTS: Novartis(NONE), Novo Nordisk Inc.(SIGNIFICANT), Amgen Inc.(SIGNIFICANT), Kaneka(SIGNIFICANT), Eli Lilly and Company(MODEST)

View Full Disclosure